These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18634372)

  • 21. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
    Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():349-53. PubMed ID: 15035150
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study.
    Savarino L; Avnet S; Greco M; Giunti A; Baldini N
    J Orthop Res; 2010 Jul; 28(7):887-92. PubMed ID: 20063383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
    Tang SJ; Meikle MC; MacLaine JK; Wong RW; Rabie BM
    Eur J Orthod; 2013 Apr; 35(2):169-74. PubMed ID: 22467569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)].
    Mochizuki Y
    Clin Calcium; 2006 Jun; 16(6):948-55. PubMed ID: 16751690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK
    Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
    Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients.
    Iwadate H; Kobayashi H; Kanno T; Asano T; Saito R; Sato S; Suzuki E; Watanabe H; Ohira H
    Int J Rheum Dis; 2014 Jan; 17(1):50-6. PubMed ID: 24472267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
    Chu P; Chao TY; Lin YF; Janckila AJ; Yam LT
    Am J Kidney Dis; 2003 May; 41(5):1052-9. PubMed ID: 12722040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
    Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
    Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
    Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U
    Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: relevance as a marker of bone resorption in jaundiced patients.
    Alvarez L; Peris P; Bedini JL; Parés A; Monegal A; Guañabens N; Mas E; Aibar C; Ballesta AM
    Calcif Tissue Int; 1999 Apr; 64(4):301-3. PubMed ID: 10089222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
    Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
    J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased osteoclast activity is associated with aggressiveness of osteosarcoma.
    Avnet S; Longhi A; Salerno M; Halleen JM; Perut F; Granchi D; Ferrari S; Bertoni F; Giunti A; Baldini N
    Int J Oncol; 2008 Dec; 33(6):1231-8. PubMed ID: 19020756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.
    Fagerlund KM; Janckila AJ; Ylipahkala H; Tiitinen SL; Nenonen A; Cheng S; Uusi-Rasi K; Yam LT; Väänänen HK; Halleen JM
    Clin Lab; 2008; 54(9-10):347-54. PubMed ID: 19097492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-generation antipsychotics and bone turnover in schizophrenia.
    Okita K; Kanahara N; Nishimura M; Yoshida T; Yasui-Furukori N; Niitsu T; Yoshida T; Ishikawa M; Kimura H; Nomura F; Iyo M
    Schizophr Res; 2014 Aug; 157(1-3):137-41. PubMed ID: 24888527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.